Country of origin: India
Pharm-Group: Antifungal agents of different groups
Manufacturers: Shreya Life Sciences (India)
International name: Terbinafine
Synonyms: Bramisil, Lamisil, Lamisil DermGel, Lamican, Medofloran, Mycoterbin, Onychon, Terbizil, Terbinafine, Terbinox, Terbifin, Termicon, Fungoterbin, Tsidokan, Exifin
Dosage forms: cream 1%, tablets 250 mg
Ingredients: Active substance - Terbinafine
Indications for use: Fungal infections of the skin, nails and hair, candidiasis of the skin and mucous membranes.
Contraindications: Hypersensitivity, severe hepatic and renal failure, blood diseases, metabolic diseases, tumors, vascular pathology of the extremities, pregnancy, breastfeeding, children under 2 years of age.
Side effects: Feeling of heaviness and pain in the epigastric region, taste disturbance, loss of appetite, nausea, diarrhea, cholestasis, neutropenia, allergic skin reactions, burning sensation, redness of the skin and itching in the area where the cream is applied.
Interaction: Histamine H-2 blockers increase plasma concentrations. Terfenadine reduces and rifampicin increases clearance by 2 times.
Overdose: Possible only when taken orally. Symptoms: headache, dizziness, epigastric pain. Treatment: symptomatic therapy.
Special instructions: During the treatment process, it is necessary to carry out antifungal treatment of shoes, socks, and stockings. Avoid getting the cream in your eyes, nose, or mouth.
Literature: Encyclopedia of Medicines 2002